Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $125,400 | 59 | 63.3% |
| Food and Beverage | $45,245 | 2,183 | 22.8% |
| Consulting Fee | $15,001 | 6 | 7.6% |
| Travel and Lodging | $12,112 | 47 | 6.1% |
| Education | $477.89 | 33 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $99,482 | 177 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $46,755 | 118 | $0 (2024) |
| ABBVIE INC. | $9,421 | 333 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $9,253 | 120 | $0 (2024) |
| UCB, Inc. | $9,090 | 187 | $0 (2024) |
| Amgen Inc. | $4,917 | 269 | $0 (2024) |
| Janssen Biotech, Inc. | $3,415 | 176 | $0 (2024) |
| PFIZER INC. | $2,006 | 132 | $0 (2024) |
| Lilly USA, LLC | $1,764 | 100 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,512 | 98 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $32,580 | 288 | GlaxoSmithKline, LLC. ($19,146) |
| 2023 | $46,133 | 297 | GlaxoSmithKline, LLC. ($27,653) |
| 2022 | $53,363 | 269 | GlaxoSmithKline, LLC. ($29,292) |
| 2021 | $23,279 | 263 | AstraZeneca Pharmaceuticals LP ($10,169) |
| 2020 | $13,161 | 193 | GlaxoSmithKline, LLC. ($10,232) |
| 2019 | $17,410 | 378 | Novartis Pharmaceuticals Corporation ($7,772) |
| 2018 | $6,492 | 340 | AbbVie, Inc. ($2,168) |
| 2017 | $5,818 | 300 | AbbVie, Inc. ($1,254) |
All Payment Transactions
2,328 individual payment records from CMS Open Payments — Page 1 of 94
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $28.45 | General |
| Category: Immunology | ||||||
| 12/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $8.41 | General |
| Category: Bone Health | ||||||
| 12/17/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 12/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $10.25 | General |
| Category: Immunology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $37.26 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $8.16 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $27.43 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.13 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.92 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $120.13 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.83 | General |
| 11/22/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Immunology | ||||||
| 11/21/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: Immunology | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.40 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $39.99 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $33.43 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Bone Health | ||||||
| 11/08/2024 | Lilly USA, LLC | TALTZ (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 1,753 | 5,340 | $472,182 | $122,723 |
| 2022 | 34 | 1,767 | 4,974 | $419,530 | $109,381 |
| 2021 | 30 | 1,459 | 4,934 | $395,935 | $102,421 |
| 2020 | 33 | 1,714 | 4,588 | $359,571 | $93,418 |
All Medicare Procedures & Services
129 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 22 | 2,280 | $156,346 | $41,206 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 161 | 314 | $117,927 | $28,125 | 23.8% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 32 | 238 | $51,673 | $13,909 | 26.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 47 | 47 | $30,467 | $7,690 | 25.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 46 | 57 | $30,183 | $7,338 | 24.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 155 | 316 | $10,038 | $3,240 | 32.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 142 | 293 | $7,911 | $2,453 | 31.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 146 | 295 | $6,876 | $2,222 | 32.3% |
| 82306 | Vitamin d-3 level | Office | 2023 | 56 | 70 | $6,237 | $1,976 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 31 | $8,286 | $1,969 | 23.8% |
| 86160 | Measurement of complement (immune system proteins), antigen, | Office | 2023 | 50 | 156 | $5,616 | $1,835 | 32.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 21 | 21 | $12,334 | $1,504 | 12.2% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 131 | 276 | $4,289 | $1,392 | 32.5% |
| 86235 | Measurement of antibody for assessment of autoimmune disorder, any method | Office | 2023 | 27 | 50 | $2,690 | $878.54 | 32.7% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2023 | 131 | 275 | $2,228 | $723.45 | 32.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 23 | 23 | $1,833 | $704.49 | 38.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 39 | 42 | $2,117 | $691.32 | 32.7% |
| 86255 | Screening test for antibody to noninfectious agent | Office | 2023 | 41 | 57 | $2,061 | $673.17 | 32.7% |
| 86803 | Hepatitis c antibody measurement | Office | 2023 | 45 | 45 | $1,926 | $615.12 | 31.9% |
| 86200 | Measurement of antibody for rheumatoid arthritis assessment | Office | 2023 | 42 | 42 | $1,632 | $520.29 | 31.9% |
| 86704 | Hepatitis b core antibody measurement | Office | 2023 | 45 | 45 | $1,627 | $519.64 | 31.9% |
| 86706 | Hepatitis b surface antibody measurement | Office | 2023 | 45 | 45 | $1,450 | $463.32 | 32.0% |
| 87340 | Detection test by immunoassay technique for hepatitis b surface antigen | Office | 2023 | 45 | 45 | $1,395 | $445.28 | 31.9% |
| 86038 | Screening test for autoimmune disorder | Office | 2023 | 34 | 34 | $1,233 | $391.05 | 31.7% |
| 86431 | Rheumatoid factor level | Office | 2023 | 54 | 64 | $1,089 | $350.28 | 32.2% |
About Dr. Joanna Geslani, D.O
Dr. Joanna Geslani, D.O is a Internal Medicine healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/08/2010. The National Provider Identifier (NPI) number assigned to this provider is 1124333703.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joanna Geslani, D.O has received a total of $198,236 in payments from pharmaceutical and medical device companies, with $32,580 received in 2024. These payments were reported across 2,328 transactions from 49 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($125,400).
As a Medicare-enrolled provider, Geslani has provided services to 6,693 Medicare beneficiaries, totaling 19,836 services with total Medicare billing of $427,944. Data is available for 4 years (2020–2023), covering 129 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Internal Medicine
- Location Dallas, TX
- Active Since 08/08/2010
- Last Updated 12/23/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1124333703
Products in Payments
- BENLYSTA (Biological) $99,464
- SAPHNELO (Biological) $46,253
- Cimzia (Drug) $8,770
- COSENTYX (Biological) $8,722
- Humira (Biological) $4,045
- Enbrel (Biological) $2,803
- RINVOQ (Biological) $2,248
- XELJANZ (Drug) $1,729
- TALTZ (Drug) $1,589
- STELARA (Biological) $1,522
- ORENCIA (Biological) $1,504
- Otezla (Drug) $1,497
- TREMFYA (Drug) $1,163
- KRYSTEXXA (Biological) $1,081
- SIMPONI ARIA (Biological) $883.40
- SKYRIZI (Biological) $814.92
- Rituxan (Biological) $805.23
- KEVZARA (Biological) $733.37
- EVENITY (Biological) $681.10
- LUPKYNIS (Drug) $671.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Dallas
Andrew Whiteley
Internal Medicine — Payments: $1.7M
Biff Palmer, Md, MD
Internal Medicine — Payments: $980,569
Dr. Robert Gottlieb, M.d. Ph.d, M.D. PH.D
Internal Medicine — Payments: $832,284
Dr. Ronan Kelly, Md, MD
Internal Medicine — Payments: $813,092
Dr. Gates Colbert, M.d, M.D
Internal Medicine — Payments: $801,349
Dr. Zoran Kurepa, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $743,379